Quality care assessment examines surgical quality for colorectal cancer patients

November 14, 2006

New research has identified indicators of surgical quality for colorectal cancer patients, according to a study published in the November 15 issue of the Journal of the National Cancer Institute.

Quality of care measures have been developed for many diseases and are used by agencies like the Centers for Medicare and Medicaid Services to evaluate the quality of care for a variety of diseases. No regulatory agencies have currently adopted quality of care measures for colorectal cancer surgery, but practice guidelines for this surgery were created by a consensus panel sponsored by the National Cancer Institute (NCI) in 2000.

Marcia L. McGory, M.D., of the University of California in Los Angeles, and colleagues updated and extended the NCI-sponsored guidelines. Using a modification of the RAND/UCLA Appropriateness Methodology, which assesses indicators of care using a series of ratings by a panel of experts, they conducted interviews with leading specialists in colorectal cancer, general surgery, and surgical oncology, and reviewed the literature to identify candidate quality of care measures for colorectal cancer surgery. An expert panel then evaluated the candidate indicators.

The authors identified 142 candidate indicators of quality care in the fields of surgical credentials, preoperative evaluation, patient-provider discussions, medication use, intraoperative care, and postoperative management. The expert panel rated 92 of these indicators as valid. The authors suggest that these indicators of quality care for colorectal cancer surgery can be used to measure the quality of care for colorectal cancer patients and create quality-improvement programs.

"These indicators identify potentially meaningful and important steps for providing high quality cancer care among health care systems, hospitals, and providers offering surgical care to patients with colorectal cancer," they write.
-end-
EMBARGOED FOR RELEASE: NOVEMBER 14 2006 16:00 EST
Journal of the National Cancer Institute

Contact: Citation:
Note: The Journal of the National Cancer Institute is published by Oxford University Press and is not affiliated with the National Cancer Institute. Attribution to the Journal of the National Cancer Institute is requested in all news coverage. Visit the Journal online at http://jncicancerspectrum.oxfordjournals.org/.

Journal of the National Cancer Institute

Related Colorectal Cancer Articles from Brightsurf:

Colorectal cancer treatment: the winning combinations
Chemotherapy has distressing side effects for patients and increases the risk of developing resistance to the treatment.

A new model to predict survival in colorectal cancer
This signature could be useful in clinical practice, especially for colorectal cancer diagnosis and therapy.

Roadmap to reducing colorectal cancer deaths
The American Gastroenterological Association has outlined a strategy to increase the number of people screened via tests that are more convenient, accurate and less expensive and tailored to people's individual cancer risks.

Study provides new insight on colorectal cancer growth
A new study by researchers at the University of Kentucky identifies a novel function of the enzyme spermine synthase to facilitate colorectal cancer growth.

Researchers ID target for colorectal cancer immunotherapy
Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have identified a target for colorectal cancer immunotherapy.

Colorectal cancer partner-in-crime identified
A protein that helps colorectal cancer cells spread to other parts of the body could be an effective treatment target.

Cancer cell reversion may offer a new approach to colorectal cancer treatment
A novel approach to reverse the progression of healthy cells to malignant ones may offer a more effective way to eradicate colorectal cancer cells with far fewer side effects, according to a KAIST research team based in South Korea.

A novel pathway to target colorectal cancer
Survival rates for patients with late-stage colorectal cancer are dismal, and new therapeutic strategies are needed to improve outcomes.

Colorectal cancer rates in Canada
The incidence of colorectal cancer among younger adults increased in recent years in this analysis of data from Canadian national cancer registries that included about 688,000 new colorectal cancers diagnosed over more than 40 years.

Cancer drugs promote stem cell properties of colorectal cancer
Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the Mannheim University Medical Center have now discovered that a certain group of cancer drugs (MEK Inhibitors) activates the cancer-promoting Wnt signalling pathway in colorectal cancer cells.

Read More: Colorectal Cancer News and Colorectal Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.